BioMarin Pharmaceutical Inc. (BMRN - Free Report) was a big mover last session on Friday, as the company saw its shares rise by nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up nearly 17% since Nov 7.
The company has seen 11 negative estimate revisions and two positive revisions in the past one month, while its Zacks Consensus Estimate moved lower over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if Friday’s move higher can last.
BioMarin currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better performing biopharmaceutical stocks include Actelion Ltd , Heska Corporation (HSKA - Free Report) and Amag Pharmaceuticals, Inc (AMAG - Free Report) , all of which carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>